Stevens Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-12,235
Closed -$633K 918
2019
Q1
$633K Sell
12,235
-30,048
-71% -$1.46M 0.03% 471
2018
Q4
$1.66M Buy
42,283
+22,224
+111% +$1.03M 0.09% 295
2018
Q3
$1.03M Buy
+20,059
New +$982K 0.04% 426
2018
Q2
Sell
-18,516
Closed -$657K 1019
2018
Q1
$657K Buy
+18,516
New +$725K 0.02% 479
2017
Q4
Sell
-16,560
Closed -$866K 1087
2017
Q3
$866K Buy
+16,560
New +$923K 0.03% 459

Other funds holding SYNH

Stevens Capital Management's SYNH Position: Q2 2019 in Review

Stevens Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2019, closing a stake of 12,235 shares — an estimated $633K sold.

Stevens Capital Management first reported a position in SYNH in Q3 2017 and held it in 5 quarters. The position peaked at $1.66M in Q4 2018. 246 funds tracked by Wall St. Rank hold SYNH as of Q2 2019.

  • Stevens Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2019 after selling out during the quarter.
  • Stevens Capital Management sold 12,235 Syneos Health, Inc. Class A Common Stock shares in Q2 2019, an estimated $633K.
  • Stevens Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2017 and held it in 5 quarters.
  • Stevens Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $1.66M in Q4 2018.
  • 246 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2019.

Based on Stevens Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.